Boehringer Ingelheim China
Website : http://www.boehringer-ingelheim.com.cn

Company Information
Boehringer Ingelheim Animal Health

The vision of the BI Animail Health business is to foster the health and well-being of mankind by contributing to an adequate supply of safe and nutritious food as well as by promoting the emotional and physical benefits arising from the human animal bond.

Based on our own research and the synergy with our human pharmaceutical expertise, Boehringer Ingelheim Animal Health delivers leading solutions to prevent, treat and cure animal diseases. We believe that it is necessary to focus to be world class. Therefore, we have made a conscious decision to focus on specific deseases and animal species, such as small animals, cattle, pigs, horses and poultry. We strive to set standards and provide for unmet medical needs. We are driven by the wish to improve animal welfare as an integral part of a healthy future for mankind.

Introduction of Asian Veterinary R&D Center (AVRDC)

The Asian Veterinary R&D Center is launched in Zhangjiang, Shanghai, which marks the expansion of Boehringer Ingelheim’s Animal Health business in China. The Center, with a 12 million euro investment, is the largest of its kind established by a multinational pharmaceutical company in China.

As a part of Boehringer Ingelheim’s international R&D network, the Asian Veterinary R&D Center is positioned to develop new and innovative products focusing on China and Asian markets.The center will be supported by our research facilities around the world, and be a supporting member itself in our global R&D organisation. The goal is to provide better solutions to farmers to protect their animals from diseases and help to provide safe and nutritious food to the people.

The Center, covering 1,900 square meters, is located within the Shanghai Zhangjiang High-Tech Park. Scientists of this state-of-the-art facility will carry out research covering all aspects of modern vaccine development. The establishment of the center is set to enhance Boehringer Ingelheim’s capacity of providing products meeting specific requirements from China’s livestock farmers which will furthermore improve the food safety and quality in the country. In addidion, this research center will also provide new job opportunities for local scientists, bring new bio-research technologies to the country and in general improve the industry level.